Fabrizio Franceschini

Dr. Fabrizio Franceschini


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2019 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Carlo CaffarelliCarlo Caffarelli
Carlo Caffarelli
FPFrancesco Paravati
Francesco Paravati
MHMay El Hachem
May El Hachem
MDmarzia duse
marzia duse
MBMarcello Bergamini
Marcello Bergamini
FCFabio Cardinale
Fabio Cardinale
The aim of this guidance is to provide recommendations to clinicians and other interested parties on chronic urticaria in children. The Italian Society for Pediatrics (SIP), the Italian Society for Allergy and Immunology (SIAIP), the Italian Society for Pediatric dermatology (SIDerP) convened a multidisciplinary panel that prepared clinical guidelines for diagnosis and management of chronic urticaria in childhood. Key questions on epidemiology, natural history, diagnosis, and management were developed. The literature was systematically searched and evaluated, recommendations were rated and algorithms for diagnosis and treatment were developed. The recommendations focus on identification of diseases and comorbidities, strategies to recognize triggering factors, improvement of treatment by individualized care.

7 December 2018 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Carlo CaffarelliCarlo Caffarelli
Carlo Caffarelli
FFFabrizio Franceschini
Fabrizio Franceschini
DCD. P. Caimmi
D. P. Caimmi
Francesca MoriFrancesca Mori
Francesca Mori
LDLucia Diaferio
Lucia Diaferio
FPFrancesco Paravati
Francesco Paravati
Drug hypersensitivity reactions (DHRs) in childhood are mainly caused by betalactam or non-betalactam antibiotics, and non-steroidal anti-inflammatory drugs (NSAIDs). Laboratory tests for identifying children who are allergic to drugs have low diagnostic accuracy and predictive value. The gold standard to diagnose DHR is represented by the drug provocation test (DPT), that aims of ascertaining the causative role of an allergen and evaluating the tolerance to the suspected drug. Different protocols through the administration of divided increasing doses have been postulated according to the type of drug and the onset of the reaction (immediate or non immediate reactions). DPT protocols differ in doses and time interval between doses. In this position paper, the Italian Pediatric Society for Allergy and Immunology provides a practical guide for provocation test to antibiotics and NSAIDs in children and adolescents.

27 September 2022 in Children
Verified
Journal Article
Open access
PDF file
SCSilvia Maria Elena Caimmi
Silvia Maria Elena Caimmi
GCGiuseppe Crisafulli
Giuseppe Crisafulli
FFFabrizio Franceschini
Fabrizio Franceschini
LLLucia Liotti
Lucia Liotti
ABAnnamaria Bianchi
Annamaria Bianchi
Carlo CaffarelliCarlo Caffarelli
Carlo Caffarelli
Intravenous iron is widely used for the treatment of iron deficiency anemia when adherence to oral iron replacement is poor. Acute hypersensitivity reactions during iron infusions are very rare but can be life threatening. Major risk factors for hypersensitivity reactions include a previous reaction to an iron infusion, a fast iron infusion rate, multiple drug allergies, atopic diseases, high serum tryptase levels, asthma, and urticaria. The management of iron infusions requires meticulous observation, and, in the event of an adverse reaction, prompt recognition and severity-related interventions by well-trained medical and nursing staff. Avoidance of IV iron products in patients with iron hypersensitivity reactions may not be considered as a standard practice.

29 November 2021
Verified
Journal Article
Open access
ABAnnamaria Bianchi
Annamaria Bianchi
PBPaolo Bottau
Paolo Bottau
ECElisabetta Calamelli
Elisabetta Calamelli
SCSilvia Caimmi
Silvia Caimmi
GCGiuseppe Crisafulli
Giuseppe Crisafulli
Carlo CaffarelliCarlo Caffarelli
Carlo Caffarelli
Hypersensitivity reactions to polyethylene glycol (PEG) is an emerging challenge and the interest about this disease is growing since PEG is considered one of the possible causes of coronavirus disease 2019 (COVID 19) vaccine-associated anaphylaxis. PEG is used in a wide variety of pharmaceutical, medical, industrial, cosmetic, and food products and can be an active ingredient or used as an excipient. PEG is present in several medications, and it may or may not be present in different formulations and dosages of the same drug. Lack of standardization nomenclature, inadequate labelling of products and lack of knowledge about PEG involvement in hypersensitivity reactions expose patients at risk of presenting multiple reactions before a diagnosis could be made. In this review we describe the main cases published in literature and propose an allergy work-up and management.

28 January 2019
Verified
Journal Article
Open access
FFFabrizio Franceschini
Fabrizio Franceschini
PBPaolo Bottau
Paolo Bottau
SCSilvia Caimmi
Silvia Caimmi
FCFabio Cardinale
Fabio Cardinale
GCGiuseppe Crisafulli
Giuseppe Crisafulli
CCCarlo Caffarelli
Carlo Caffarelli
Adverse drug reactions include drug hypersensitivity reactions (DHRs), which can be immunologically mediated or non-immunologically mediated. The high number of DHRs unconfirmed and/or self-reported is a frequent problem in daily clinical practice, with considerable impact on future prescription choices and patient health. It is important to distinguish between hypersensitivity and non-hypersensitivity reactions by adopting a structured diagnostic approach to confirm or discard the suspected drug, not only to avoid life-threatening reactions, but also to reduce the frequent over-diagnosis of DHRs.

27 April 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
LGLisa Ghezzi
Lisa Ghezzi
SASimone Arrighi
Simone Arrighi
RPRiccardo Petrini
Riccardo Petrini
MBmonica bini
monica bini
LALivia Vittori Antisari
Livia Vittori Antisari
RGRoberto Giannecchini
Roberto Giannecchini
This study deals with arsenic distribution in groundwater, soil and edible vegetables in the densely populated area of the Versilia Plain (Tuscany region, Italy), addressing potential impacts on people’s health. The data revealed high As concentrations in some domestic irrigation wells, exceeding 1200 µg/L. The average As concentration in topsoil and subsoil was 39 and 46 mg/kg, respectively, with the highest concentration reaching about 200 mg/kg. Arsenic concentrates in plant roots compared with the edible parts; in tomato fruits, black cabbage leaves and edible leek parts As reached about 0.2 mg/kg, 0.4 mg/kg and 3 mg/kg, respectively. Geochemical and hydrostratigraphic data suggest that As in soils and alluvial sediments originated from mineralized and historical upstream mining areas. The exposure routes for both non-carcinogenic and carcinogenic risk assessment here considered include soil ingestion, dermal absorption, soil dust inhalation and vegetable consumption. For non-carcinogenic and carcinogenic effects, the hazard was higher than the acceptance threshold. The calculated soil screening levels resulted even lower than the guideline soil-concentration imposed by Italian regulations, and this poses an issue on the actual meaning of arsenic regulatory thresholds.